London afternoon: Thos. Cook soars on bid spec
9th Jun 2009 14:39
It's been a see-saw day for London's leading shares which are now predominantly firmer, after US markets opened moderately higher. Lloyds Banking Group has confirmed press reports that it is to close its Cheltenham & Gloucester branch network in a move that will see 1,000 jobs go. Lloyds also annou
Read moreLondon midday: Defence stocks beat a retreat
9th Jun 2009 12:05
Leading shares are now lower, dragged down by expectations of a weak start on Wall Street and by a trimming of the strong early gains made by miners. Lloyds Banking Group is still in the blue on reports it is to axe a further 1,500 jobs and close the branch network of Cheltenham & Gloucester. Gla
Read moreLondon open: Blue chips start well
9th Jun 2009 08:47
Last night's late recovery in Wall Street has given London a modest boost this morning. Lloyds is going well on reports it is to axe a further 1,500 jobs and close the branch network of Cheltenham & Gloucester. Miners are also in demand again following yesterday's rally in the US. Vedanta and Antof
Read moreLondon pre-open: Stocks to edge higher
9th Jun 2009 07:40
Last night's late recovery in Wall Street is set to give London a modest boost this morning. The FTSE 100 is predicted to open up about 15 points as the Dow Jones erased an earlier 100-point deficit to close just in the blue. Heritage Oil is merging with Turkish exploration and production group Ge
Read moreGlaxo enters Chinese flu market
9th Jun 2009 07:15
Drug giant GlaxoSmithKline has entered into an agreement with Chinese gene engineering drug group Shenzhen Neptunus Interlong Bio-Technique to develop and manufacture influenza vaccines for China. The agreement, which will include making vaccines for seasonal, pre-pandemic and pandemic influenza, w
Read moreBroker tips: Glaxo, Rio Tinto, MITIE
18th May 2009 13:22
Drugs giant GlaxoSmithKline confirmed on Friday it has received orders for 127.9m doses of its anti-viral vaccine from four governments stockpiling medicines to be used in the treatment of the H1N1 flu virus. Broker Charles Stanley has estimated that these orders, along with other potential orders,
Read moreBroker snap: Swine flu to boost Glaxo top line by £600m+
18th May 2009 12:39
Drugs giant GlaxoSmithKline confirmed on Friday it has received orders for 127.9m doses of its anti-viral vaccine from four governments stockpiling medicines to be used in the treatment of the H1N1 flu virus. Broker Charles Stanley has estimated that these orders, along with other potential orders,
Read moreGSK gets orders for new swine flu vaccine
15th May 2009 15:25
GlaxoSmithKline plans to begin production of a new vaccine for the H1N1 swine flu virus once it receives the virus seed from the WHO and said it has already received orders from a number of governments. The first doses of the vaccine are expected to be available four to six months after the virus s
Read moreFTSE 100 movers: Profit rise points Compass higher
13th May 2009 13:44
Caterer Compass is bucking the general downward trend after it reported a stronger-than-expected 41% rise in half-year profits thanks to new contract wins and cost cuts. Another food related stock, Unilever, whose range includes Pot Noodles and Persil, is boosted by a positive note from Charles Sta
Read moreGSK to buy 16% stake in Aspen
12th May 2009 08:16
GlaxoSmithKline has agreed to buy a 16% shareholding in South African based pharmaceuticals company Aspen Pharmacare. The group said the deal is part of a wide ranging agreement which includes combining commercial activities in Sub-Saharan Africa and the divestment of several assets to Aspen. On
Read more